About Actin-like protein 7A
Actin-like protein 7A (ACTL7A) is a protein
from Homo sapiens identified by UniProt accession
Q9Y615, 435 residues long.
MolForge cross-references it against 0 known binders and
104 disease associations.
Target properties
| Protein name | Actin-like protein 7A |
| UniProt accession | Q9Y615 |
| Gene | ACTL7A |
| Organism | Homo sapiens |
| Length | 435 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (104)
Diseases linked to this target (Open Targets).
- heel bone mineral density · score 0.28
- balding measurement · score 0.22
- bone quantitative ultrasound measurement · score 0.20
- central corneal thickness · score 0.17
- keratoconus · score 0.17
- neurofibrillary tangles measurement · score 0.16
- azoospermia · score 0.10
- lobe attachment · score 0.10
- facial morphology measurement · score 0.10
- adolescent idiopathic scoliosis · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y615-F1 | alphafold | PREDICTED | 84.55 | — |
Amino-acid sequence (435 residues)
MWAPPAAIMG DGPTKKVGNQ APLQTQALQT ASLRDGPAKR AVWVRHTSSE PQEPTESKAA KERPKQEVTK AVVVDLGTGY CKCGFAGLPR PTHKISTTVG KPYMETAKTG DNRKETFVGQ ELNNTNVHLK LVNPLRHGII VDWDTVQDIW EYLFRQEMKI APEEHAVLVS DPPLSPHTNR EKYAEMLFEA FNTPAMHIAY QSRLSMYSYG RTSGLVVEVG HGVSYVVPIY EGYPLPSITG RLDYAGSDLT AYLLGLLNSA GNEFTQDQMG IVEDIKKKCC FVALDPIEEK KVPLSEHTIR YVLPDGKEIQ LCQERFLCSE MFFKPSLIKS MQLGLHTQTV SCLNKCDIAL KRDLMGNILL CGGSTMLSGF PNRLQKELSS MCPNDTPQVN VLPERDSAVW TGGSILASLQ GFQPLWVHRF EYEEHGPFFL YRRCF
Explore Actin-like protein 7A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets